Empagliflozin for treating neutropenia and neutrophil dysfunction in 21 infants with glycogen storage disease 1b

Sarah C. Gruenert, Matthias Gautschi, Joshua Baker, Monica Boyer, Alberto Burlina, Thomas Casswall, Willemijn Corpeleijn, Kismet Ciki, Melanie Cotter, Ellen Crushell, Terry G. J. Derks, Dorothea Haas, Sebile Kilavuz, Sandra D. K. Kingma, Stanley H. Korman, Anne Kozek, Corinne de Laet, Helen Mundy, Marie Cecile Nassogne, Victor QuinteroAlessandro Rossi, Johannes Spenger (Co-author), Ronen Spiegel, Xavier Stephenne, Darko Stojkov, Galit Tal, Maria Veiga-da Cunha, Saskia B. Wortmann* (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

Fingerprint

Dive into the research topics of 'Empagliflozin for treating neutropenia and neutrophil dysfunction in 21 infants with glycogen storage disease 1b'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science